» Articles » PMID: 29203589

Lymph Node Metastases in Colon Cancer Are Polyclonal

Overview
Journal Clin Cancer Res
Specialty Oncology
Date 2017 Dec 6
PMID 29203589
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Recent studies have highlighted the existence of subclones in tumors. Lymph nodes are generally the first location of metastasis for most solid epithelial tumors, including colorectal cancer. We sought to understand the genetic origin of lymph node metastasis in colorectal cancer by evaluating the relationship between colorectal cancer subclones present in primary tumors and lymph nodes. A total of 33 samples from seven colorectal cancers, including two or three spatially disparate regions from each primary tumor and one to four matched lymph nodes for each tumor, underwent next-generation whole-exome DNA sequencing, Affymetrix OncoScan SNP arrays, and targeted deep confirmatory sequencing. We performed mapping between SNPs and copy number events from the primary tumor and matched lymph node samples, allowing us to profile heterogeneity and the mutational origin of lymph node metastases. The computational method PyClone was used to define subclones within each tumor. The method Clonality Inference in Tumors Using Phylogeny (CITUP) was subsequently used to infer phylogenetic relationships among subclones. We found that there was substantial heterogeneity in mutations and copy number changes among all samples from any given patient. For each patient, the primary tumor regions and matched lymph node metastases were each polyclonal, and the clonal populations differed from one lymph node to another. In some patients, the cancer cell populations in a given lymph node originated from multiple distinct regions of a tumor. Our data support a model of lymph node metastatic spread in colorectal cancer whereby metastases originate from multiple waves of seeding from the primary tumor over time. .

Citing Articles

Invasion and metastasis in cancer: molecular insights and therapeutic targets.

Li Y, Liu F, Cai Q, Deng L, OuYang Q, Zhang X Signal Transduct Target Ther. 2025; 10(1):57.

PMID: 39979279 PMC: 11842613. DOI: 10.1038/s41392-025-02148-4.


Quantifying cell divisions along evolutionary lineages in cancer.

Blohmer M, Cheek D, Hung W, Kessler M, Chatzidimitriou F, Wang J Nat Genet. 2025; 57(3):706-717.

PMID: 39905260 DOI: 10.1038/s41588-025-02078-5.


Assessing the clinical utility of tumor invasion proportion of lymph nodes for enhanced risk stratification in N1 colorectal cancer.

Chen R, Xu D, Fan X, Qiao Y, Jiang X, Hao J Am J Cancer Res. 2025; 14(12):5826-5838.

PMID: 39803664 PMC: 11711517. DOI: 10.62347/DFXC4525.


Expression and clinical significance of Numb and Notch-1 proteins between tissue of colon cancer and regional lymph node metastases.

Ma J, Zhen J, Yang N, Meng C, Lian Y Front Oncol. 2024; 14:1467517.

PMID: 39691600 PMC: 11649626. DOI: 10.3389/fonc.2024.1467517.


Multiparametric MRI-based radiomic model for predicting lymph node metastasis after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.

Wei Q, Chen L, Hou X, Lin Y, Xie R, Yu X Insights Imaging. 2024; 15(1):163.

PMID: 38922456 PMC: 11208366. DOI: 10.1186/s13244-024-01726-4.


References
1.
Edwards B, Noone A, Mariotto A, Simard E, Boscoe F, Henley S . Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. 2013; 120(9):1290-314. PMC: 3999205. DOI: 10.1002/cncr.28509. View

2.
McPherson A, Roth A, Laks E, Masud T, Bashashati A, Zhang A . Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancer. Nat Genet. 2016; 48(7):758-67. DOI: 10.1038/ng.3573. View

3.
Kim T, Jung S, An C, Lee S, Baek I, Kim M . Subclonal Genomic Architectures of Primary and Metastatic Colorectal Cancer Based on Intratumoral Genetic Heterogeneity. Clin Cancer Res. 2015; 21(19):4461-72. DOI: 10.1158/1078-0432.CCR-14-2413. View

4.
Findlay J, Castro-Giner F, Makino S, Rayner E, Kartsonaki C, Cross W . Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy. Nat Commun. 2016; 7:11111. PMC: 4822033. DOI: 10.1038/ncomms11111. View

5.
Baldus S, Schaefer K, Engers R, Hartleb D, Stoecklein N, Gabbert H . Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases. Clin Cancer Res. 2010; 16(3):790-9. DOI: 10.1158/1078-0432.CCR-09-2446. View